{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:45:32Z","timestamp":1782960332517,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022030","name":"Silence Therapeutics plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL142975"],"award-info":[{"award-number":["R01HL142975"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse Swiss Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_153436"],"award-info":[{"award-number":["310030_153436"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["314730_173127"],"award-info":[{"award-number":["314730_173127"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["114.430\\u2009IP-LS"],"award-info":[{"award-number":["114.430\\u2009IP-LS"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtha.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:02:36Z","timestamp":1743030156000},"page":"2133-2150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S"],"prefix":"10.1016","volume":"23","author":[{"given":"Raja Prince","family":"Eladnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Schaeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Aretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Vrotniakaite-Bajerciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"\u00c7aku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafika","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Desir\u00e9","family":"Reina Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Dames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Eisermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Brodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Casini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna A.","family":"Kremer Hovinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanjaneyulu","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike A.","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinku","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Ahnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-4863","authenticated-orcid":false,"given":"Anne","family":"Angelillo-Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.03.021_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(11)61139-2","article-title":"Modern haemophilia care","volume":"379","author":"Berntorp","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.03.021_bib3","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1111\/j.1365-2516.2012.02771.x","article-title":"Why should we care about quality of life in persons with haemophilia?","volume":"18","author":"Aledort","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.021_bib4","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2017.11.003","article-title":"Cytokines in the pathogenesis of hemophilic arthropathy","volume":"39","author":"Wojdasiewicz","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jtha.2025.03.021_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jtha.2024.04.010","article-title":"Ultra-Long factor VIII: a major step forward toward a hemophilia-free mind","volume":"22","author":"Hermans","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2209226","article-title":"Efanesoctocog alfa prophylaxis for patients with severe hemophilia A","volume":"388","author":"von Drygalski","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057479","article-title":"Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity","volume":"8","author":"Sampei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.03.021_bib10","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood.2020009217","article-title":"Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies","volume":"137","author":"Callaghan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/nm.2942","article-title":"A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model","volume":"18","author":"Kitazawa","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.2020010331","article-title":"A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice","volume":"138","author":"\u00d8stergaard","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102181","article-title":"Mim8, a novel factor VIIIa mimetic bispecific antibody, shows favorable safety and pharmacokinetics in healthy adults","volume":"7","author":"Persson","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1616569","article-title":"Targeting of antithrombin in hemophilia A or B with RNAi therapy","volume":"377","author":"Pasi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib15","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S2352-3026(23)00037-6","article-title":"Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A\/B): a multicentre, open-label, randomised, phase 3 trial","volume":"10","author":"Srivastava","year":"2023","journal-title":"Lancet Haematol"},{"issue":"suppl 1","key":"10.1016\/j.jtha.2025.03.021_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood-2023-187624","volume":"142","author":"Pipe","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40265-023-01912-6","article-title":"Concizumab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2025.03.021_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2216455","article-title":"Phase 3 trial of concizumab in hemophilia with inhibitors","volume":"389","author":"Matsushita","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib19","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2019001542","article-title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors: phase 2 trial results","volume":"134","author":"Shapiro","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.18495","article-title":"Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: phase II study results","volume":"200","author":"Mahlangu","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.03.021_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2016-05-718635","article-title":"Design and characterization of an APC-specific serpin for the treatment of hemophilia","volume":"129","author":"Polderdijk","year":"2017","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtha.2025.03.021_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood-2022-159631","article-title":"Serpinpc in persons with severe hemophilia (PwH): updated results from a multi-center, multi-part, first-in-human study","volume":"140","author":"Baglin","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.2023020005","article-title":"Safety and efficacy of an anti-human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models","volume":"142","author":"Jiang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib24","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/s41467-020-16720-9","article-title":"Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.03.021_bib25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/blood.2019000281","article-title":"Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia","volume":"134","author":"Aymonnier","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/jth.14940","article-title":"Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generation","volume":"18","author":"Kawecki","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib27","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood-2017-09-800326","article-title":"Targeting anticoagulant protein S to improve hemostasis in hemophilia","volume":"131","author":"Prince","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib28","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlb\u00e4ck","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.03.021_bib29","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1016\/S0021-9258(19)85485-6","article-title":"Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding protein","volume":"268","author":"Fern\u00e1ndez","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.021_bib30","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1016\/S0021-9258(18)60959-7","article-title":"The protein S-binding site localized to the central core of C4b-binding protein","volume":"262","author":"Hillarp","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.021_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.148.1.207","article-title":"Human C4-binding protein. I. Isolation and characterization","volume":"148","author":"Scharfstein","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/geno.1994.1308","article-title":"The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse","volume":"21","author":"Rodr\u00edguez de C\u00f3rdoba","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.jtha.2025.03.021_bib33","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI39325","article-title":"Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis","volume":"119","author":"Burstyn-Cohen","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.03.021_bib34","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.2019003630","article-title":"Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus","volume":"135","author":"Calzavarini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V70.1.301.301","article-title":"Biosynthesis and secretion of functional protein S by a human megakaryoblastic cell line (MEG-01)","volume":"70","author":"Ogura","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib36","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V66.6.1452.1452","article-title":"Identification and quantitation of protein S in human platelets","volume":"66","author":"Schwarz","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jtha.2023.01.033","article-title":"Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short","volume":"21","author":"Dahlb\u00e4ck","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOH.0000000000000838","article-title":"Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation","volume":"31","author":"Ahnstr\u00f6m","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2025.03.021_bib39","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.112.250928","article-title":"Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C","volume":"32","author":"Chattopadhyay","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.03.021_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(90)90201-F","article-title":"Neonatal purpura fulminans associated with homozygous protein S deficiency","volume":"335","author":"Mahasandana","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.03.021_bib70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0037-1614440","article-title":"Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency","volume":"81","author":"Pung-amritt","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib41","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM198412133112401","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S","volume":"311","author":"Comp","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib42","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib43","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2009-03-209031","article-title":"Generation and phenotypic analysis of protein S-deficient mice","volume":"114","author":"Saller","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.omtn.2020.05.026","article-title":"Less is more: novel hepatocyte-targeted siRNA conjugates for treatment of liver-related disorders","volume":"21","author":"Weing\u00e4rtner","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jtha.2025.03.021_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.03.021_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1365-2516.2012.02780.x","article-title":"A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate)","volume":"18","author":"Pastoft","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.021_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2008.02954.x","article-title":"Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice","volume":"6","author":"\u00d8vlisen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/hae.12950","article-title":"Haemarthrosis model in mice: BSS - Bleeding Severity Score assessment system","volume":"22","author":"Hakobyan","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.021_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2516.2005.01107.x","article-title":"Thrombin generation and phenotypic correlation in haemophilia A","volume":"11","author":"Beltr\u00e1n-Miranda","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.021_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib51","first-page":"30","article-title":"Thrombin generation assay as a laboratory monitoring tool during bypassing therapy in patients with hemophilia and inhibitors","volume":"42","author":"Mancuso","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib52","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1182\/blood-2012-05-432005","article-title":"Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S","volume":"120","author":"Ahnstr\u00f6m","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib53","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2009-11-256610","article-title":"Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain","volume":"115","author":"Andersson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib54","doi-asserted-by":"crossref","first-page":"eadk5836","DOI":"10.1126\/sciadv.adk5836","article-title":"TFPI\u03b1 anticoagulant function is highly dependent on protein S in vivo","volume":"10","author":"Petri","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2025.03.021_bib55","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2014-01-551812","article-title":"TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain","volume":"123","author":"Regli\u0144ska-Matveyev","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12185-015-1898-6","article-title":"Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban","volume":"103","author":"Tripodi","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2025.03.021_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.jtha.2025.03.021_bib58","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm.3847","article-title":"An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia","volume":"21","author":"Sehgal","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.2023023404","article-title":"Fitusiran reduces bleeding in factor X-deficient mice","volume":"144","author":"Verhenne","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.021_bib60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jtha.2025.03.021_bib61","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jtha.2025.03.021_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/nat.2022.0010","article-title":"Cross-species translation of biophase half-life and potency of GalNAc-conjugated siRNAs","volume":"32","author":"Boianelli","year":"2022","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.jtha.2025.03.021_bib63","doi-asserted-by":"crossref","first-page":"32038","DOI":"10.1074\/jbc.M110.148452","article-title":"Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the \u03b2-chain of C4b-binding protein","volume":"285","author":"Carlsson","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.021_bib64","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.03.021_bib65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.1982.tb22153.x","article-title":"Serum C-reactive protein levels in disease","volume":"389","author":"Morley","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtha.2025.03.021_bib66","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1111\/jth.15506","article-title":"Detailed analysis of anti-emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia A","volume":"19","author":"Kaneda","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.021_bib71","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/bloodadvances.2021006403","article-title":"Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors","volume":"6","author":"Shapiro","year":"2022","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"10.1016\/j.jtha.2025.03.021_bib68","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2022-170245","article-title":"Pre-clinical characterization of VGA039, an anti-protein S monoclonal antibody being developed as a universal hemostatic agent for various bleeding disorders","volume":"140","author":"Leong","year":"2022","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:12:29Z","timestamp":1782958349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625002016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1538783625002016"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.021","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}